ReviewCell Biology

The adaptor molecule RIAM integrates signaling events critical for integrin-mediated control of immune function and cancer progression

See allHide authors and affiliations

Sci. Signal.  22 Aug 2017:
Vol. 10, Issue 493, eaam8298
DOI: 10.1126/scisignal.aam8298

Article Information

vol. 10 no. 493

PubMed: 
Published By: 
Print ISSN: 
Online ISSN: 
History: 
  • Received January 23, 2017
  • Accepted July 25, 2017

Author Information

  1. Nikolaos Patsoukis1,2,
  2. Kankana Bardhan1,2,
  3. Jessica D. Weaver1,2,
  4. Duygu Sari1,2,
  5. Alvaro Torres-Gomez3,
  6. Lequn Li1,2,*,
  7. Laura Strauss1,2,
  8. Esther M. Lafuente3, and
  9. Vassiliki A. Boussiotis1,2,
  1. 1Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  2. 2Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  3. 3School of Medicine, Unit of Immunology, Complutense University of Madrid, 28040 Madrid, Spain.
  1. Corresponding author. Email: vboussio{at}bidmc.harvard.edu
  • * Present address: Division of Thoracic Surgery at Tongji Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China.

Altmetric

Article usage

Article usage: August 2017 to October 2018

AbstractFullPdf
Aug 20172466643728
Sep 2017371163108
Oct 2017150142101
Nov 201719811380
Dec 2017598627
Jan 2018897367
Feb 20181466452
Mar 2018587815
Apr 2018486241
May 2018415228
Jun 2018384114
Jul 2018302313
Aug 201817617
Sep 201805911
Oct 201803112

Navigate This Article